AstraZeneca has agreed to transfer its global rights for respiratory medicines Eklira (Aclidinium bromide) and Duaklir (Aclidinium bromide/formoterol) to Covis Pharma Group.

by admin
0 comment
 

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy
WP2Social Auto Publish Powered By : XYZScripts.com